AKBA
Akebia Therapeutics Inc
Price:  
1.85 
USD
Volume:  
1,743,305.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AKBA WACC - Weighted Average Cost of Capital

The WACC of Akebia Therapeutics Inc (AKBA) is 7.6%.

The Cost of Equity of Akebia Therapeutics Inc (AKBA) is 7.80%.
The Cost of Debt of Akebia Therapeutics Inc (AKBA) is 6.75%.

Range Selected
Cost of equity 6.50% - 9.10% 7.80%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 6.50% - 7.00% 6.75%
WACC 6.4% - 8.8% 7.6%
WACC

AKBA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.58 0.76
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.50% 9.10%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.09 0.09
Cost of debt 6.50% 7.00%
After-tax WACC 6.4% 8.8%
Selected WACC 7.6%